Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 15:12:22 UTC |
---|
Update Date | 2021-09-14 15:40:23 UTC |
---|
HMDB ID | HMDB0002961 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Dihydrotestosterone |
---|
Description | Dihydrotestosterone is a potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. -- Pubchem; Dihydrotestosterone (DHT) (INN: androstanolone) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5-alpha-reductase by means of reducing the alpha 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. DHT is thought to be approximately 30 times more potent than testosterone because of increased affinity to the androgen receptor. |
---|
Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
17beta-Hydroxyandrostan-3-one | ChEBI | 4,5alpha-Dihydrotestosterone | ChEBI | 5alpha-DHT | ChEBI | 5alpha-Dihydrotestosterone | ChEBI | Androstanolona | ChEBI | Androstanolone | ChEBI | Androstanolonum | ChEBI | DHT | ChEBI | Dihydrotestosteron | ChEBI | Stanolone | ChEBI | 17beta-Hydroxy-5alpha-androstan-3-one | Kegg | Andractim | Kegg | 17b-Hydroxyandrostan-3-one | Generator | 17Β-hydroxyandrostan-3-one | Generator | 4,5a-Dihydrotestosterone | Generator | 4,5Α-dihydrotestosterone | Generator | 5a-DHT | Generator | 5Α-DHT | Generator | 5a-Dihydrotestosterone | Generator | 5Α-dihydrotestosterone | Generator | 17b-Hydroxy-5a-androstan-3-one | Generator | 17Β-hydroxy-5α-androstan-3-one | Generator | 17beta-Hydroxy-3-oxo-5alpha-androstanone | HMDB | 17b-Hydroxy-3-oxo-5a-androstanone | HMDB | 17Β-hydroxy-3-oxo-5α-androstanone | HMDB | 17-Hydroxy-androstan-3-one | HMDB | 17-Hydroxyandrostan-3-one | HMDB | 17b-Hydroxy-3-androstanone | HMDB | 4-Dihydrotestosterone | HMDB | 5-a-Androstanolone | HMDB | 5-alpha-Androstanolone | HMDB | 5a-Androstan-17b-ol-3-one | HMDB | 5a-Androstan-3-on-17b-ol | HMDB | 5alpha-Androstan-17beta-ol-3-one | HMDB | 5b-Androstan-3-on-17b-ol | HMDB | Anaboleen | HMDB | Anabolex | HMDB | Androlone | HMDB | Androstalone | HMDB | Cristerona MB | HMDB | Drolban | HMDB | Neodrol | HMDB | Proteina | HMDB | Protona | HMDB | Stanaprol | HMDB | Stanorone | HMDB | 17beta Hydroxy 5alpha androstan 3 one | HMDB | 5 alpha Dihydrotestosterone | HMDB | 5 beta Dihydrotestosterone | HMDB | 5 beta-Dihydrotestosterone | HMDB | Besins-iscovesco brand OF androstanolone | HMDB | 5-alpha-DHT | HMDB | Anaprotin | HMDB | Berenguer infale brand OF androstanolone | HMDB | Dihydroepitestosterone | HMDB | 5 alpha DHT | HMDB | 5 alpha-Dihydrotestosterone | HMDB | Besins iscovesco brand OF androstanolone | HMDB | Dihydrotestosterone, 5-alpha | HMDB | 17 beta Hydroxy 5 beta androstan 3 one | HMDB | 17 beta-Hydroxy-5 beta-androstan-3-one | HMDB | 5-alpha Dihydrotestosterone | HMDB | Cuxson brand OF androstanolone | HMDB | Gelovit | HMDB | beta-Hydroxy-5 beta-androstan-3-one, 17 | HMDB | DIHYDROTESTOSTERONE | ChEBI |
|
---|
Chemical Formula | C19H30O2 |
---|
Average Molecular Weight | 290.4403 |
---|
Monoisotopic Molecular Weight | 290.224580204 |
---|
IUPAC Name | (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one |
---|
Traditional Name | (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one |
---|
CAS Registry Number | 521-18-6 |
---|
SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 |
---|
InChI Key | NVKAWKQGWWIWPM-ABEVXSGRSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-oxosteroid
- 3-oxo-5-alpha-steroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Cyclic alcohol
- Cyclic ketone
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organooxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 181 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 525 mg/mL at 25 °C | Not Available | LogP | 3.55 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Dihydrotestosterone,1TMS,isomer #1 | C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C)CC[C@@H]12 | 2624.6 | Semi standard non polar | 33892256 | Dihydrotestosterone,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@@H]2O | 2596.3 | Semi standard non polar | 33892256 | Dihydrotestosterone,1TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C=C(O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O | 2578.9 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C=C(O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2624.6 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C=C(O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2620.3 | Standard non polar | 33892256 | Dihydrotestosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C=C(O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2972.9 | Standard polar | 33892256 | Dihydrotestosterone,2TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C)CC[C@@H]12 | 2624.0 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C)CC[C@@H]12 | 2602.3 | Standard non polar | 33892256 | Dihydrotestosterone,2TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C)CC[C@@H]12 | 2972.3 | Standard polar | 33892256 | Dihydrotestosterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 2887.8 | Semi standard non polar | 33892256 | Dihydrotestosterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]32)C1 | 2864.9 | Semi standard non polar | 33892256 | Dihydrotestosterone,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 | 2823.1 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]32)C1 | 3175.7 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]32)C1 | 2999.3 | Standard non polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]32)C1 | 3215.1 | Standard polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 | 3163.3 | Semi standard non polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 | 3059.2 | Standard non polar | 33892256 | Dihydrotestosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 | 3215.2 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Dihydrotestosterone EI-B (Non-derivatized) | splash10-015c-8970000000-ef0c6a4fd9c52be30284 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Dihydrotestosterone EI-B (Non-derivatized) | splash10-001l-1790000000-60cff73adc796876d469 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Dihydrotestosterone EI-B (Non-derivatized) | splash10-015c-8970000000-ef0c6a4fd9c52be30284 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Dihydrotestosterone EI-B (Non-derivatized) | splash10-001l-1790000000-60cff73adc796876d469 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrotestosterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-03gj-0390000000-9eeab8ff981af1be878c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrotestosterone GC-MS (1 TMS) - 70eV, Positive | splash10-001j-2129000000-dbb4c264166c851e22c1 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrotestosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrotestosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-000x-9870000000-f6d80b2a53942c9af50b | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 30V, Positive-QTOF | splash10-0bta-0930000000-078d7455103eab0cf1ee | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 40V, Positive-QTOF | splash10-08gj-0900000000-9f326ea5c1c454997fd3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 20V, Positive-QTOF | splash10-0a4i-0390000000-85c48da18cebca66ba3c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 10V, Positive-QTOF | splash10-0006-0090000000-f81b1315d55db1d47ec4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 50V, Positive-QTOF | splash10-02cv-0900000000-9d78808dd524e4ca6c50 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dihydrotestosterone 30V, Positive-QTOF | splash10-0bta-0930000000-49751ee4f183943f62fa | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 10V, Positive-QTOF | splash10-00dl-0190000000-32b12edcbd16045a4a2e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 20V, Positive-QTOF | splash10-00dl-0390000000-a2704bedea3c7bf92d65 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 40V, Positive-QTOF | splash10-016r-2790000000-d1a3cc2c786b582339b3 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 10V, Negative-QTOF | splash10-000i-0090000000-62e8fc46490b14aee68a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 20V, Negative-QTOF | splash10-000i-0090000000-d712d8c85325f4935c06 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 40V, Negative-QTOF | splash10-05fu-2190000000-d8e9f38bc70955a04aea | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 10V, Positive-QTOF | splash10-0006-0090000000-48f400d66433b81d9a66 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 20V, Positive-QTOF | splash10-0aba-1950000000-acfc6238e1a13c48e859 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 40V, Positive-QTOF | splash10-066s-2900000000-1bc41566c7dc5d14c903 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 10V, Negative-QTOF | splash10-000i-0090000000-c8c452fd99c6bb4f3631 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 20V, Negative-QTOF | splash10-000i-0090000000-c8c452fd99c6bb4f3631 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrotestosterone 40V, Negative-QTOF | splash10-000i-0090000000-20b22a4e3152e3639e64 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
- Endoplasmic reticulum
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Epidermis
- Fibroblasts
- Hair
- Kidney
- Liver
- Neuron
- Ovary
- Prostate
- Skeletal Muscle
- Testis
- Thyroid Gland
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.000172-0.00207 uM | Newborn (0-30 days old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000200 - 0.00110 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000860 - 0.00340 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.00041 +/- 0.00016 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0054 +/- 0.0028 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | <0.00006.89 uM | Newborn (0-30 days old) | Female | Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete | | details | Blood | Detected and Quantified | 0.000900-0.00390 uM | Adult (>18 years old) | Male | X-linked ichthyosis | | details | Blood | Detected and Quantified | 0.0054 +/- 0.0029 uM | Adult (>18 years old) | Both | Psychiatric disorder | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0000010000 +/- 0.000004135 uM | Adult (>18 years old) | Not Specified | Leuprolide acetate-induced hypogonadism | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00001275 +/- 0.00001792 uM | Adult (>18 years old) | Not Specified | Leuprolide acetate-induced hypogonadism with testosterone replacment | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Alcoholism |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Major depressive disorder |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete |
---|
- Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub 2008 Jan 8. [PubMed:18182448 ]
| X-linked ichthyosis |
---|
- Lykkesfeldt G, Bennett P, Lykkesfeldt AE, Micic S, Moller S, Svenstrup B: Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clin Endocrinol (Oxf). 1985 Oct;23(4):385-93. [PubMed:3864567 ]
|
|
---|
Associated OMIM IDs | - 608516 (Major depressive disorder)
- 613743 (Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete)
- 308100 (X-linked ichthyosis)
|
---|
External Links |
---|
DrugBank ID | DB02901 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023086 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 10189 |
---|
KEGG Compound ID | C03917 |
---|
BioCyc ID | 17-BETA-HYDROXY-5ALPHA-ANDROSTAN-3-O |
---|
BiGG ID | 42776 |
---|
Wikipedia Link | Dihydrotestosterone |
---|
METLIN ID | 2789 |
---|
PubChem Compound | 10635 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16330 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 5ADTSTSTERONE |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Gardi, Rinaldo; Castelli, Pier Paolo; Gandolfi, Roberto; Ercoli, Alberto. Conversion of 5a-pregnane-3,2O-dione to dihydrotestosterone. (1961), 1250-7. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Tincello DG, Saunders PT, Hodgins MB, Simpson NB, Edwards CR, Hargreaves TB, Wu FC: Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. Clin Endocrinol (Oxf). 1997 Apr;46(4):497-506. [PubMed:9196614 ]
- Gratterola R: Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res. 1978 Sep;38(9):3051-4. [PubMed:679211 ]
- Choi MH, Kim JN, Chung BC: Rapid HPLC-electrospray tandem mass spectrometric assay for urinary testosterone and dihydrotestosterone glucuronides from patients with benign prostate hyperplasia. Clin Chem. 2003 Feb;49(2):322-5. [PubMed:12560362 ]
- Farthing MJ, Rees LH, Edwards CR, Dawson AM: Male gonadal function in coeliac disease: 2. Sex hormones. Gut. 1983 Feb;24(2):127-35. [PubMed:6682819 ]
- Aganovic I, Alac M, Cabrijan T, Grizelj V, Korsic M, Misjak-Vitez M, Reiner Z, Suchanek E, Simunic V, Zjacic-Rotkvic V: [National consensus on hyperandrogenemia]. Lijec Vjesn. 1996 Sep;118(9):189-90. [PubMed:9011736 ]
- Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S: Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May;89(5):2179-84. [PubMed:15126539 ]
- Sato T, Sonoda T, Itami S, Takayasu S: Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis). Br J Dermatol. 1998 Nov;139(5):806-10. [PubMed:9892945 ]
- Christiansen K, Knussmann R: Androgen levels and components of aggressive behavior in men. Horm Behav. 1987 Jun;21(2):170-80. [PubMed:3610056 ]
- Hammond GL, Leinonen P, Bolton NJ, Vihko R: Measurement of sex hormone binding globulin in human amniotic fluid: its relationship to protein and testosterone concentrations, and fetal sex. Clin Endocrinol (Oxf). 1983 Apr;18(4):377-84. [PubMed:6683603 ]
- Boccon-Gibod L, Laudat MH, Guiban D, Steg A: Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels. Eur Urol. 1988;15(1-2):99-102. [PubMed:3215246 ]
- Misao R, Itoh N, Mori H, Fujimoto J, Tamaya T: Sex hormone-binding globulin mRNA levels in human uterine endometrium. Eur J Endocrinol. 1994 Dec;131(6):623-9. [PubMed:7804446 ]
- Toscano V, Horton R: Circulating dihydrotestosterone may not reflect peripheral formation. J Clin Invest. 1987 Jun;79(6):1653-8. [PubMed:3584464 ]
- Pineiro V, Casabiell X, Peino R, Lage M, Camina JP, Menendez C, Baltar J, Dieguez C, Casanueva F: Dihydrotestosterone, stanozolol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not in male samples of omental adipose tissue in vitro: lack of effect of testosterone. J Endocrinol. 1999 Mar;160(3):425-32. [PubMed:10076188 ]
- Dawood MY, Saxena BB: Testosterone and dihydrotestosterone in maternal and cord blood and in amniotic fluid. Am J Obstet Gynecol. 1977 Sep 1;129(1):37-42. [PubMed:900166 ]
- Geller J, Candari CD: Comparison of dihydrotestosterone levels in prostatic cancer metastases and primary prostate cancer. Prostate. 1989;15(2):171-5. [PubMed:2798234 ]
- Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A: Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci. 2002 Jun;966:131-42. [PubMed:12114267 ]
|
---|